Cargando…

FRI306 Natural History Of Untreated Prolactinoma

Disclosure: M. Sadek: None. N. Sandila: None. D.B. Clarke: None. S.A. Imran: None. BACKGROUND Prolactinomas (PRLomas) are the most common functioning pituitary tumors, and the majority are microPRLomas (<10 mm in size). Current guidelines do not support treating asymptomatic or minimally symptoma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadek, Maryanne, Sandila, Navjot, Clarke, David B, Imran, Syed Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Neuroendocrinology & Pituitary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554462/ http://dx.doi.org/10.1210/jendso/bvad114.1241

Ejemplares similares

FRI296 Somatostatin Receptor 5 Staining In Prolactinomas
por: Mehta, Sonal, et al.
Publicado: (2023)

FRI314 Prolactinoma And Macroprolactin; A Diagnostic Dilemma
por: Farooqi, Aneeba, et al.
Publicado: (2023)

FRI320 The Various Clinical Outcomes Of Giant Prolactinomas In Men
por: Gilis-Januszewska, Aleksandra, et al.
Publicado: (2023)

FRI323 Prolactinoma Recurrence With Testosterone Treatment In Transgender Male
por: Arnouk, Nelly, et al.
Publicado: (2023)

FRI300 Prolactinoma And Pregnancy: A Systematic Review And Meta-analysis
por: Bandeira, Diego Barata, et al.
Publicado: (2023)

FRI316 A Rare Case Of Mono-hormonal Silent Prolactinoma
por: Esaki, Yumiko, et al.
Publicado: (2023)

FRI322 Lack Of Tumor Size Change With Long-term Cabergoline For Prolactinoma
por: Bendaram, Snigdha Reddy, et al.
Publicado: (2023)

FRI321 Aggressive Prolactinoma Empirically Treated With Cabergoline Leading To Rapid CSF Leak
por: Yau, Alice, et al.
Publicado: (2023)

FRI303 PRL-R Variants Are Not Only Associated With Prolactinomas But Also With Dopamine Agonist Resistance
por: de Castro Moreira, Andrea Ramos, et al.
Publicado: (2023)

FRI299 Efficacy And Safety Of Endoscopic Transsphenoidal Resection For Prolactinoma: A Retrospective Case-series
por: Zandbergen, Ingrid M, et al.
Publicado: (2023)

FRI297 Hemoglobin Decline As A Signal For Hyperprolactinemia Onset Prior To Prolactinoma Diagnosis In Hypogonadal Men
por: Rudman, Yaron, et al.
Publicado: (2023)

FRI305 Impulse Control Disorders In Patients With Prolactinomas And Non-Functioning Pituitary Adenomas Treated With Dopamine Agonists
por: Kolitz, Tamara, et al.
Publicado: (2023)

FRI298 Serum Prolactin To Tumor Size Ratio As An Effective Parameter To Accurately Distinguish Prolactinoma From NFPT
por: Mishra, Ipsita, et al.
Publicado: (2023)

FRI304 Prolactinomas In A Pituitary Center From Ecuador: Clinical Presentation With High Prevalence Of Giant Adenomas And Delayed Diagnosis
por: Quishpe Lopez, Darlyng Patricia, et al.
Publicado: (2023)

ODP306 Diplopia as Presenting Manifestation of Acromegaly
por: Rjoob, Hani, et al.
Publicado: (2022)

Giant Prolactinoma Causing Proptosis and Stroke
por: Wortham, Joy, et al.
Publicado: (2021)

Prolactinoma in Two Brothers - Unidentified Genetic Cause Versus Co-Incidence?
por: Gundluru, Rajani, et al.
Publicado: (2021)

SAT623 Everolimus For Treatment-refractory Prolactinomas
por: Lin, Andrew L, et al.
Publicado: (2023)

SUN-443 Surgical Management of Cystic Prolactinomas
por: Nevzati, Edin, et al.
Publicado: (2019)

Giant Prolactinomas: An Experience From South India
por: S, Vishwanath, et al.
Publicado: (2021)

ODP364 Prolactinomas in men: management challenges
por: Baciu, Ionela, et al.
Publicado: (2022)

SUN-306 The Interaction Between Thiazide-Associated Hyponatremia and Acute Illness in Hospitalised Patients
por: Nikoi, Ebenezer N A, et al.
Publicado: (2020)

SAT616 Differentiating Resistant Prolactinoma From Macroprolactinemia
por: Lacount, Steven, et al.
Publicado: (2023)

SAT612 Granulomatous Mastitis: An Unusual Presentation Of Prolactinoma
por: Alkaissi, Hussam R, et al.
Publicado: (2023)

SAT-478 Successful Management of an Atypical Prolactinoma with Radiotherapy
por: Bowes, Christa, et al.
Publicado: (2019)

MON-266 The Association Between Prolactinomas and Weight Gain
por: Tariq, Zunera, et al.
Publicado: (2020)

Cerebrospinal Fluid Leak After Medical Management of Prolactinoma
por: Pechman, Amanda, et al.
Publicado: (2021)

SAT-306 Muscarinic and Adrenergic Receptor Cooperativity in a Human Adrenocortical Carcinoma Cell Line
por: Malaiyandi, Latha, et al.
Publicado: (2020)

SAT604 An Extensively Invasive Giant Prolactinoma Associated With CDH23 Mutation
por: Alghamdi, Balgees, et al.
Publicado: (2023)

SUN-447 Screening of Genetic Alterations in Patients with Giant Prolactinomas
por: Chaves, Carolina, et al.
Publicado: (2019)

SUN-LB073 Giant Prolactinomas: Recidive (Case Report)
por: Galesanu, Corina
Publicado: (2019)

FRI335 Late Surgical Management For Symptom Control In A Patient With History Of Pituitary Apoplexy
por: Zahra, Sundas, et al.
Publicado: (2023)

Discordance Between Prolactinoma Size and Prolactin Level: An Unusual Laboratory Finding
por: Dawaher, Wafa, et al.
Publicado: (2021)

SUN-442 EGFR/ErbB2 Targeted Therapy for Aggressive Prolactinomas
por: Cooper, Odelia, et al.
Publicado: (2019)

MON-324 Management and Therapeutic Response Comparison in Prolactinomas According to Tumor Size
por: Flores-Cardenas, Romina
Publicado: (2020)

PMON169 D2R Expression in Dopamine-Agonist Resistant Prolactinomas
por: Levine, Alice, et al.
Publicado: (2022)

FRI302 Umar Durrani
por: Durrani, Umar Safwaan, et al.
Publicado: (2023)

THU100 Case Of A Large Suprasellar-clival Mass: Prolactinoma Vs Paraganglioma
por: Madera Marin, Luis Norberto, et al.
Publicado: (2023)

SAT620 Dopamine Challenge: Treatment Of Pituitary Macroadenoma/Prolactinoma In Patient On Antipsychotic Medication
por: Bazhenov, Aleksei, et al.
Publicado: (2023)

SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline
por: Madan Paramasivan, Ameena, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o1e1dnr7949ojf5n5jnhj44dhi